Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fondazione Matilde Tettamanti Menotti De Marchi Onlus
Age
1–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children (1-17) and adults (18-75 years old);
Relapsed or refractory adult and pediatric B- ALL as defined for the presence of bone marrow with ≥ 5% lymphoblasts by morphologic assessment, or if \<5%, with at least 1% of molecular disease at PCR;
Evidence of CD19 tumor expression in bone marrow and/or peripheral blood by flow cytometry;
Diagnosis of CD19 positive ALL in the bone marrow, and/or peripheral blood and/or extramedullary sites with the exclusion of Central Nervous System (CNS) if CNS-3 disease.
You may not be if
GVHD Grades II-IV for patients who had previously been transplanted; 2. Any cell therapy in the previous 30 days;
Patient with concomitant life-threatening infectious disease;
Lansky/Karnofsky score \<60;
Patients with hepatic or renal disease as specific above;
Pregnant or breast-feeding females;
Rapidly progressive disease that in the estimation of the investigator and sponsor would compromise ability to complete study therapy;